TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -2.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 44 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ORGO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
109 100 110 130 115 127 87 101 150 225 37 44 457
26 28 29 29 27 31 24 28 36 50 38 24 148
83 72 81 101 88 96 63 73 114 175 -0.9 20 309
10 12 13 16 10 12 11 10 13 10 15 18 57
64 48 72 77 72 70 73 74 80 100 65 54 299
75 73 85 115 82 85 83 84 93 110 64 71 338
8.1 -1.3 -3.9 -14 6.2 10 -20 -11 22 65 -65 -51 -29
0.4 0.5 0.5 0.6 0.5 0.1 1.0 0.7 0.4 0.2
7.6 -1.8 -4.3 -15 5.8 10 -26 -12 21 63 -68 -51 -35
4.5 -1.2 -2.2 2.5 -6.5 2.6 -6.9 -2.4 -0.4 20 -12 45 52
3.2 -0.6 -2.1 -17 12 7.7 -19 -9.4 22 44 -56 -99 -90
14 11 0.1 -9.7 11 15 -20 -5.2 28 70 -56 -47 -4.7

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?